OSL 7.69% 1.2¢ oncosil medical ltd

Ann: OncoSil AGM CEO Presentation, page-107

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. Al.
    198 Posts.
    lightbulb Created with Sketch. 114
    Barton, M. B. et al. Estimating the demand for radiotherapy from the evidence: a review of changes from 2003 to 2012. Radiother. Oncol. J. Eur. Soc. Ther. Radiol. Oncol. 112, 140–144 (2014). - ‘Radiation is used in approximately 50% of all cancer treatments1. The key objective in cancer radiotherapy is to achieve a high therapeutic efficacy by maximizing damage to the tumor whilst minimizing damage to surrounding healthy tissue2,3,4. In conventional external beam radiotherapy, the dose that can be delivered to a tumor is often limited by the presence of an adjacent critical organ. This means that not all tumor cells may receive a lethal dose of radiation, thus limiting the treatment efficacy.’
 
watchlist Created with Sketch. Add OSL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.